Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Personalized Medicine market report explains the definition, types, applications, major countries, and major players of the Personalized Medicine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Mylan NV
Eli Lilly
Abbott Laboratories
Merck & Co, Inc
Pfizer, Inc
GlaxoSmithKline PLC
Novartis AG
Bayer AG
Amgen, Inc
AstraZeneca
By Type:
Personalized Medicine Diagnostics
Personalized Medical Care
Personalized Medicine Therapeutics
Personalized Nutrition and Wellness
By End-User:
Oncology
Central Nervous System (CNS)
Immunology
Respiratory
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Personalized Medicine Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Personalized Medicine Outlook to 2028- Original Forecasts
-
2.2 Personalized Medicine Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Personalized Medicine Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Personalized Medicine Market- Recent Developments
-
6.1 Personalized Medicine Market News and Developments
-
6.2 Personalized Medicine Market Deals Landscape
7 Personalized Medicine Raw Materials and Cost Structure Analysis
-
7.1 Personalized Medicine Key Raw Materials
-
7.2 Personalized Medicine Price Trend of Key Raw Materials
-
7.3 Personalized Medicine Key Suppliers of Raw Materials
-
7.4 Personalized Medicine Market Concentration Rate of Raw Materials
-
7.5 Personalized Medicine Cost Structure Analysis
-
7.5.1 Personalized Medicine Raw Materials Analysis
-
7.5.2 Personalized Medicine Labor Cost Analysis
-
7.5.3 Personalized Medicine Manufacturing Expenses Analysis
8 Global Personalized Medicine Import and Export Analysis (Top 10 Countries)
-
8.1 Global Personalized Medicine Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Personalized Medicine Export by Region (Top 10 Countries) (2017-2028)
9 Global Personalized Medicine Market Outlook by Types and Applications to 2022
-
9.1 Global Personalized Medicine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Personalized Medicine Diagnostics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Personalized Medical Care Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Personalized Medicine Therapeutics Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Personalized Nutrition and Wellness Consumption and Growth Rate (2017-2022)
-
9.2 Global Personalized Medicine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Central Nervous System (CNS) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Immunology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Respiratory Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Personalized Medicine Market Analysis and Outlook till 2022
-
10.1 Global Personalized Medicine Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Personalized Medicine Consumption (2017-2022)
-
10.2.2 Canada Personalized Medicine Consumption (2017-2022)
-
10.2.3 Mexico Personalized Medicine Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Personalized Medicine Consumption (2017-2022)
-
10.3.2 UK Personalized Medicine Consumption (2017-2022)
-
10.3.3 Spain Personalized Medicine Consumption (2017-2022)
-
10.3.4 Belgium Personalized Medicine Consumption (2017-2022)
-
10.3.5 France Personalized Medicine Consumption (2017-2022)
-
10.3.6 Italy Personalized Medicine Consumption (2017-2022)
-
10.3.7 Denmark Personalized Medicine Consumption (2017-2022)
-
10.3.8 Finland Personalized Medicine Consumption (2017-2022)
-
10.3.9 Norway Personalized Medicine Consumption (2017-2022)
-
10.3.10 Sweden Personalized Medicine Consumption (2017-2022)
-
10.3.11 Poland Personalized Medicine Consumption (2017-2022)
-
10.3.12 Russia Personalized Medicine Consumption (2017-2022)
-
10.3.13 Turkey Personalized Medicine Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Personalized Medicine Consumption (2017-2022)
-
10.4.2 Japan Personalized Medicine Consumption (2017-2022)
-
10.4.3 India Personalized Medicine Consumption (2017-2022)
-
10.4.4 South Korea Personalized Medicine Consumption (2017-2022)
-
10.4.5 Pakistan Personalized Medicine Consumption (2017-2022)
-
10.4.6 Bangladesh Personalized Medicine Consumption (2017-2022)
-
10.4.7 Indonesia Personalized Medicine Consumption (2017-2022)
-
10.4.8 Thailand Personalized Medicine Consumption (2017-2022)
-
10.4.9 Singapore Personalized Medicine Consumption (2017-2022)
-
10.4.10 Malaysia Personalized Medicine Consumption (2017-2022)
-
10.4.11 Philippines Personalized Medicine Consumption (2017-2022)
-
10.4.12 Vietnam Personalized Medicine Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Personalized Medicine Consumption (2017-2022)
-
10.5.2 Colombia Personalized Medicine Consumption (2017-2022)
-
10.5.3 Chile Personalized Medicine Consumption (2017-2022)
-
10.5.4 Argentina Personalized Medicine Consumption (2017-2022)
-
10.5.5 Venezuela Personalized Medicine Consumption (2017-2022)
-
10.5.6 Peru Personalized Medicine Consumption (2017-2022)
-
10.5.7 Puerto Rico Personalized Medicine Consumption (2017-2022)
-
10.5.8 Ecuador Personalized Medicine Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Personalized Medicine Consumption (2017-2022)
-
10.6.2 Kuwait Personalized Medicine Consumption (2017-2022)
-
10.6.3 Oman Personalized Medicine Consumption (2017-2022)
-
10.6.4 Qatar Personalized Medicine Consumption (2017-2022)
-
10.6.5 Saudi Arabia Personalized Medicine Consumption (2017-2022)
-
10.6.6 United Arab Emirates Personalized Medicine Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Personalized Medicine Consumption (2017-2022)
-
10.7.2 South Africa Personalized Medicine Consumption (2017-2022)
-
10.7.3 Egypt Personalized Medicine Consumption (2017-2022)
-
10.7.4 Algeria Personalized Medicine Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Personalized Medicine Consumption (2017-2022)
-
10.8.2 New Zealand Personalized Medicine Consumption (2017-2022)
11 Global Personalized Medicine Competitive Analysis
-
11.1 Mylan NV
-
11.1.1 Mylan NV Company Details
-
11.1.2 Mylan NV Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Mylan NV Personalized Medicine Main Business and Markets Served
-
11.1.4 Mylan NV Personalized Medicine Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Eli Lilly
-
11.2.1 Eli Lilly Company Details
-
11.2.2 Eli Lilly Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Eli Lilly Personalized Medicine Main Business and Markets Served
-
11.2.4 Eli Lilly Personalized Medicine Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Abbott Laboratories
-
11.3.1 Abbott Laboratories Company Details
-
11.3.2 Abbott Laboratories Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Abbott Laboratories Personalized Medicine Main Business and Markets Served
-
11.3.4 Abbott Laboratories Personalized Medicine Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Merck & Co, Inc
-
11.4.1 Merck & Co, Inc Company Details
-
11.4.2 Merck & Co, Inc Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Merck & Co, Inc Personalized Medicine Main Business and Markets Served
-
11.4.4 Merck & Co, Inc Personalized Medicine Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Pfizer, Inc
-
11.5.1 Pfizer, Inc Company Details
-
11.5.2 Pfizer, Inc Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Pfizer, Inc Personalized Medicine Main Business and Markets Served
-
11.5.4 Pfizer, Inc Personalized Medicine Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 GlaxoSmithKline PLC
-
11.6.1 GlaxoSmithKline PLC Company Details
-
11.6.2 GlaxoSmithKline PLC Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 GlaxoSmithKline PLC Personalized Medicine Main Business and Markets Served
-
11.6.4 GlaxoSmithKline PLC Personalized Medicine Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Novartis AG
-
11.7.1 Novartis AG Company Details
-
11.7.2 Novartis AG Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Novartis AG Personalized Medicine Main Business and Markets Served
-
11.7.4 Novartis AG Personalized Medicine Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Bayer AG
-
11.8.1 Bayer AG Company Details
-
11.8.2 Bayer AG Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Bayer AG Personalized Medicine Main Business and Markets Served
-
11.8.4 Bayer AG Personalized Medicine Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Amgen, Inc
-
11.9.1 Amgen, Inc Company Details
-
11.9.2 Amgen, Inc Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Amgen, Inc Personalized Medicine Main Business and Markets Served
-
11.9.4 Amgen, Inc Personalized Medicine Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 AstraZeneca
-
11.10.1 AstraZeneca Company Details
-
11.10.2 AstraZeneca Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 AstraZeneca Personalized Medicine Main Business and Markets Served
-
11.10.4 AstraZeneca Personalized Medicine Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Personalized Medicine Market Outlook by Types and Applications to 2028
-
12.1 Global Personalized Medicine Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Personalized Medicine Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Personalized Medical Care Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Personalized Medicine Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Personalized Nutrition and Wellness Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Personalized Medicine Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Central Nervous System (CNS) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Immunology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Respiratory Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Personalized Medicine Market Analysis and Outlook to 2028
-
13.1 Global Personalized Medicine Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Personalized Medicine Consumption Forecast (2022-2028)
-
13.2.2 Canada Personalized Medicine Consumption Forecast (2022-2028)
-
13.2.3 Mexico Personalized Medicine Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Personalized Medicine Consumption Forecast (2022-2028)
-
13.3.2 UK Personalized Medicine Consumption Forecast (2022-2028)
-
13.3.3 Spain Personalized Medicine Consumption Forecast (2022-2028)
-
13.3.4 Belgium Personalized Medicine Consumption Forecast (2022-2028)
-
13.3.5 France Personalized Medicine Consumption Forecast (2022-2028)
-
13.3.6 Italy Personalized Medicine Consumption Forecast (2022-2028)
-
13.3.7 Denmark Personalized Medicine Consumption Forecast (2022-2028)
-
13.3.8 Finland Personalized Medicine Consumption Forecast (2022-2028)
-
13.3.9 Norway Personalized Medicine Consumption Forecast (2022-2028)
-
13.3.10 Sweden Personalized Medicine Consumption Forecast (2022-2028)
-
13.3.11 Poland Personalized Medicine Consumption Forecast (2022-2028)
-
13.3.12 Russia Personalized Medicine Consumption Forecast (2022-2028)
-
13.3.13 Turkey Personalized Medicine Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Personalized Medicine Consumption Forecast (2022-2028)
-
13.4.2 Japan Personalized Medicine Consumption Forecast (2022-2028)
-
13.4.3 India Personalized Medicine Consumption Forecast (2022-2028)
-
13.4.4 South Korea Personalized Medicine Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Personalized Medicine Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Personalized Medicine Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Personalized Medicine Consumption Forecast (2022-2028)
-
13.4.8 Thailand Personalized Medicine Consumption Forecast (2022-2028)
-
13.4.9 Singapore Personalized Medicine Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Personalized Medicine Consumption Forecast (2022-2028)
-
13.4.11 Philippines Personalized Medicine Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Personalized Medicine Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Personalized Medicine Consumption Forecast (2022-2028)
-
13.5.2 Colombia Personalized Medicine Consumption Forecast (2022-2028)
-
13.5.3 Chile Personalized Medicine Consumption Forecast (2022-2028)
-
13.5.4 Argentina Personalized Medicine Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Personalized Medicine Consumption Forecast (2022-2028)
-
13.5.6 Peru Personalized Medicine Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Personalized Medicine Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Personalized Medicine Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Personalized Medicine Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Personalized Medicine Consumption Forecast (2022-2028)
-
13.6.3 Oman Personalized Medicine Consumption Forecast (2022-2028)
-
13.6.4 Qatar Personalized Medicine Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Personalized Medicine Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Personalized Medicine Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Personalized Medicine Consumption Forecast (2022-2028)
-
13.7.2 South Africa Personalized Medicine Consumption Forecast (2022-2028)
-
13.7.3 Egypt Personalized Medicine Consumption Forecast (2022-2028)
-
13.7.4 Algeria Personalized Medicine Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Personalized Medicine Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Personalized Medicine Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Personalized Medicine
-
Figure of Personalized Medicine Picture
-
Table Global Personalized Medicine Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Personalized Medicine Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Personalized Medicine Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Personalized Medical Care Consumption and Growth Rate (2017-2022)
-
Figure Global Personalized Medicine Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Personalized Nutrition and Wellness Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Central Nervous System (CNS) Consumption and Growth Rate (2017-2022)
-
Figure Global Immunology Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Personalized Medicine Consumption by Country (2017-2022)
-
Table North America Personalized Medicine Consumption by Country (2017-2022)
-
Figure United States Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Canada Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Mexico Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Table Europe Personalized Medicine Consumption by Country (2017-2022)
-
Figure Germany Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure UK Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Spain Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Belgium Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure France Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Italy Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Denmark Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Finland Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Norway Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Sweden Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Poland Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Russia Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Turkey Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Table APAC Personalized Medicine Consumption by Country (2017-2022)
-
Figure China Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Japan Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure India Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Thailand Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Singapore Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Philippines Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Table South America Personalized Medicine Consumption by Country (2017-2022)
-
Figure Brazil Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Colombia Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Chile Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Argentina Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Peru Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Table GCC Personalized Medicine Consumption by Country (2017-2022)
-
Figure Bahrain Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Oman Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Qatar Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Table Africa Personalized Medicine Consumption by Country (2017-2022)
-
Figure Nigeria Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure South Africa Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Egypt Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure Algeria Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Table Oceania Personalized Medicine Consumption by Country (2017-2022)
-
Figure Australia Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Personalized Medicine Consumption and Growth Rate (2017-2022)
-
Table Mylan NV Company Details
-
Table Mylan NV Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan NV Personalized Medicine Main Business and Markets Served
-
Table Mylan NV Personalized Medicine Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Personalized Medicine Main Business and Markets Served
-
Table Eli Lilly Personalized Medicine Product Portfolio
-
Table Abbott Laboratories Company Details
-
Table Abbott Laboratories Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Personalized Medicine Main Business and Markets Served
-
Table Abbott Laboratories Personalized Medicine Product Portfolio
-
Table Merck & Co, Inc Company Details
-
Table Merck & Co, Inc Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Personalized Medicine Main Business and Markets Served
-
Table Merck & Co, Inc Personalized Medicine Product Portfolio
-
Table Pfizer, Inc Company Details
-
Table Pfizer, Inc Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc Personalized Medicine Main Business and Markets Served
-
Table Pfizer, Inc Personalized Medicine Product Portfolio
-
Table GlaxoSmithKline PLC Company Details
-
Table GlaxoSmithKline PLC Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline PLC Personalized Medicine Main Business and Markets Served
-
Table GlaxoSmithKline PLC Personalized Medicine Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Personalized Medicine Main Business and Markets Served
-
Table Novartis AG Personalized Medicine Product Portfolio
-
Table Bayer AG Company Details
-
Table Bayer AG Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Personalized Medicine Main Business and Markets Served
-
Table Bayer AG Personalized Medicine Product Portfolio
-
Table Amgen, Inc Company Details
-
Table Amgen, Inc Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen, Inc Personalized Medicine Main Business and Markets Served
-
Table Amgen, Inc Personalized Medicine Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Personalized Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Personalized Medicine Main Business and Markets Served
-
Table AstraZeneca Personalized Medicine Product Portfolio
-
Figure Global Personalized Medicine Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Personalized Medical Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Personalized Medicine Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Personalized Nutrition and Wellness Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Central Nervous System (CNS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Personalized Medicine Consumption Forecast by Country (2022-2028)
-
Table North America Personalized Medicine Consumption Forecast by Country (2022-2028)
-
Figure United States Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Personalized Medicine Consumption Forecast by Country (2022-2028)
-
Figure Germany Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Personalized Medicine Consumption Forecast by Country (2022-2028)
-
Figure China Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Personalized Medicine Consumption Forecast by Country (2022-2028)
-
Figure Brazil Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Personalized Medicine Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Personalized Medicine Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Personalized Medicine Consumption Forecast by Country (2022-2028)
-
Figure Australia Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)
-
